Web-based Document Management System purpose-built for pharmaceutical regulatory compliance, enabling companies to automate and manage document lifecycle processes with FDA 21 CFR Part 11 compliance, electronic signatures, and audit trails.
pharmaREADY DMS is a regulatory-compliant, web-based Document Management System that provides centralized control over the entire document lifecycle, from creation through archival. The system is part of the fully integrated pharmaREADY Suite, which also includes eCTD (Electronic Common Technical Document), SPL (Structured Product Label Management), and TRMS (Training Records Management System) modules.
Launched in 2005 and developed by Navitas Life Sciences, pharmaREADY DMS is purpose-built for pharmaceutical and life sciences organisations navigating complex regulatory landscapes. The platform automates document management processes with deep understanding of FDA 21 CFR Part 11, EU Annex 11, cGMP, and HIPAA compliance requirements. Core capabilities include electronic signatures, automated version control, comprehensive audit trails, and configurable approval workflows supporting both sequential and parallel review cycles.
The system enables collaborative workflow across departments to manage both GxP and non-GxP documents throughout their lifecycle. The vendor states that integration across all pharmaREADY modules enables regulatory submissions to be prepared 40% faster than other systems. Implementation is designed for rapid deployment, with the platform typically operational within 3-4 weeks including complete IQ/OQ validation and end-user training.
Available as both cloud-based SaaS and on-premise deployment, pharmaREADY DMS serves 200+ global biopharma customers. The vendor reports 100% customer satisfaction. Notable pharmaceutical clients include Hikma Pharmaceuticals, Reliance Life Sciences (1000+ users for 10+ years), and BioVectra. The parent company, Navitas Life Sciences, maintains ISO 27001, ISO 9001, and ISO 15189 certifications and has achieved zero FDA observations in its last three inspections.
pharmaREADY DMS serves pharmaceutical, biotech, and contract research organisations.
Pharmaceutical Edition
pharmaREADY DMS is purpose-built exclusively for pharmaceutical and life sciences organizations, with functionality designed specifically for FDA 21 CFR Part 11, EU Annex 11, cGMP, and HIPAA compliance
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
pharmaREADY DMS is delivered as a fully web-based platform accessible via standard browsers with no client-side installation required. The system offers flexible deployment options including cloud-based SaaS (Software-as-a-Service) and on-premise installation to meet varying organizational requirements for data residency and infrastructure preferences.
The platform is architected as part of the integrated pharmaREADY Suite, enabling data flow and integration across all modules (DMS, eCTD, SPL, TRMS). The vendor states this integration enables submission preparation 40% faster than standalone systems. The system supports both GxP-regulated and non-GxP document management within a unified platform.
Implementation is designed for rapid deployment with the application operational within 3-4 weeks including complete IQ (Installation Qualification) and OQ (Operational Qualification) validation and comprehensive end-user training. Post-implementation, customers receive 24/7 application support from Navitas Life Sciences global support personnel.
The platform is built with deep understanding of FDA 21 CFR Part 11, EU Annex 11, cGMP, HIPAA, and GAMP5 compliance requirements, with security architecture based on parent company Navitas Life Sciences' ISO 27001:2022 certified information security management system.
Pricing is undisclosed. pharmaREADY DMS follows an enterprise licensing model based on organisational requirements, number of users, and deployment option (cloud vs. on-premise). The vendor states "lowest total cost of ownership in the industry."
Pricing factors include: number of concurrent users, storage requirements, selected modules (DMS standalone or integrated suite), deployment preference (SaaS cloud or on-premise), and support level. Implementation fees cover IQ/OQ validation, configuration, and training within the 3-4 week deployment timeline.
Annual maintenance includes 24/7 post-sales application support, platform updates and enhancements, ongoing validation support to minimize re-validation efforts, and access to Navitas regulatory experts. Cloud deployments follow a subscription model with predictable annual costs. On-premise deployments offer perpetual licensing options with annual maintenance agreements.
Specific pricing requires contacting Navitas Life Sciences' sales team, which provides a customised quote based on requirements. Customer testimonials describe pharmaREADY as "the most reasonably priced package," particularly for mid-market pharmaceutical and generic drug manufacturers.
pharmaREADY DMS implementation follows a rapid deployment methodology with the complete system operational within 3-4 weeks. This timeline includes Installation Qualification (IQ), Operational Qualification (OQ) validation, and comprehensive end-user training to ensure teams are productive from day one.
The vendor describes the platform as designed for intuitive use with a minimal learning curve. Navitas Life Sciences provides implementation support to configure workflows, approval processes, and document templates specific to each organization's requirements. The system supports migration from legacy document management systems with data import capabilities.
Integration across the pharmaREADY Suite (DMS, eCTD, SPL, TRMS) is pre-built, enabling data flow for regulatory submission preparation. For organizations using only DMS module, the system operates independently while maintaining upgrade paths to additional modules.
Validation support includes pre-written IQ/OQ protocols aligned with FDA 21 CFR Part 11 and GAMP5 requirements. Post-implementation, customers receive 24/7 global application support from Navitas technical personnel. The platform includes regular updates and enhancements while maintaining validated state with minimal re-validation requirements.
Both cloud and on-premise deployment options are available, with cloud deployments offering fastest implementation (typically 2-3 weeks) and on-premise installations requiring 3-4 weeks for infrastructure configuration and validation.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Hikma Pharmaceuticals reports being "very pleased with the user-friendly software which meets ICH expectations," with the support team providing "fast response and solutions which is critical when working with authorities." Reliance Life Sciences has used the system for over 10 years with 1000+ users, noting their "dependence on the system has grown immensely" for managing both GxP and non-GxP documents across departments. Customers also cite the 3-4 week implementation timeline, the interface, regulatory compliance features, total cost of ownership, integration across pharmaREADY modules — which the vendor states enables 40% faster submission preparation — and 24/7 support from Navitas technical teams.
Limitations & Open Questions
Third-party review coverage is limited, leaving prospects to assess user sentiment mainly from vendor-published testimonials. Documented integration is scoped to the pharmaREADY suite (DMS, eCTD, SPL, TRMS); no third-party integrations beyond the suite are described.
Help the community
Share your experience with pharmaREADY DMS anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section